Second Quarter 2023 Highlights
“Disciplined capital allocation and using our strong financial position wisely to maximize the impact of our highest-conviction companies are crucial to long-term value creation. During the quarter, our dedication to these priorities and our unique ability to seize opportunities in the current market is manifested by our USD 100m investment in Spring Health. Through this investment, Spring Health represents our largest aggregate investment since we commenced our transformation in 2018. We believe Spring Health also has the potential to become one of the most successful investments in Kinnevik’s history.”
Georgi Ganev, CEO of Kinnevik
Kinnevik in numbers
54.0bn
Sek, Net asset value
192
Nav per share
(3)%
Change in nav Q/Q
(12)%
Change in nav Y/Y
(9)%
1 year TSR
+3%
5 year TSR
Conference Call 10am CET
Those who wish to ask questions during the conference call are welcome to register via the below link. Participants will receive dial-in numbers and confirmation code upon registration. Please make sure to register and dial in a few minutes before the call begins.